V R INFRASPACE LTD Q4 RESULTS
10 Best Mobile Phones under Rs. 30,000 from Leading Brands in India (2024)
In the competitive world of smartphones, finding the best option under 30,000 can be a challenge. This article explores some high-quality mobile phones in this budget range, highlighting models that offer exceptional performance, advanced features, and excellent value for money. Whether you are looking for powerful processors, impressive cameras, or long-lasting battery life, this article provides an overview of the best mobile phones under 30,000 that deliver premium experiences without breaking the bank.
10 Best Mobile Phones under Rs. 45,000 in India to Transform your Tech Game (2024)
Explore the best mobile phones under 45,000 that offer cutting-edge technology and impressive features, including powerful processors, stunning displays, and advanced camera systems. Whether you are after blazing-fast 5G connectivity, exceptional gaming capabilities, or a sleek design with robust build quality, these smartphones deliver top-notch performance and value. With options from renowned brands like OnePlus, iQOO, and Honor, this selection caters to a variety of preferences and needs, ensuring you get both quality and value.
India's GDP hits 15-month low of 6.7% in Q1FY25
India's gross domestic product grew at 6.7 per cent for Q1FY25. Experts were anticipating moderate growth for this quarter, attributing their expectations to the general elections of 2024, a slump in urban consumption and a previously-sluggish rural growth. The Reserve Bank of India had in August projected India's GDP to grow at 7.1 per cent for the first quarter of fiscal year 2024-25.
Zomato captains India Inc’s dream Team XI with over 1,000% profit growth
The June quarter saw Zomato and 10 other companies achieving over 1,000% profit growth. Zomato's profit skyrocketed 12,550% year-on-year. Other remarkable performers were Shakti Pumps and Lotus Chocolate. Experts advise focusing on growth outlooks rather than past profits when making investment decisions.
Q1 results shocker: 40 companies report more than 50% drop in profit
The profits of 40 Indian companies have plummeted by more than 50% in the June quarter, primarily due to higher raw material costs and unfavorable base effects. Notable names like Allcargo Logistics and Rajesh Exports saw drastic declines. Analysts suggest cautious investment strategies amid high market valuations and slowing profit growth.
FII selloff hits Rs 30,000 crore since Budget but why aren't alarm bells ringing?
FIIs have sold Indian stocks worth Rs 30,000 crore since the Budget due to high valuations and global economic concerns. Despite the sell-off, Indian markets remained resilient due to strong domestic investor support. Analysts expect FII behavior to improve by November as key global economic conditions stabilize.
- Go To Page 1
Zydus Lifesciences Q1 results: Net profit jumps 31% to Rs 1420 crore
The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 38.4% YoY to Rs 2084 crore. On QoQ, EBITDA increased 27.8%.
Alkem Labs Q1 Results: Net profit zooms 90% to Rs 545 crore
The company reported Rs 287 crore in the corresponding quarter of the previous year. Revenue from operations grew 2.2% y-o-y to Rs 3032 crore in Q1FY25.
Biocon Q1 Results: Net Jumps 6-fold to Rs 660 cr on one-time gain
Biocon's net profit for Q1FY25 surged to ₹660 crore, up from ₹101 crore the previous year, primarily due to a one-time gain from selling Biocon Biologics' domestic branded formulation business. Revenue remained flat at ₹3,433 crore. Core EBITDA saw a decline, although overall EBITDA improved significantly due to the one-off gain.
Page Industries Q1 Results: Net profit rises 4.3% YoY to Rs 165.22 crore
The revenue increased by 3.9% from Rs. 1,229.07 crores to Rs. 1,277.52 crores in the period under review. The sales volume grew by 2.6% year-on-year to 5.74 crore pieces
Suzlon Energy shares rally 33% since Q1 results announcement
Suzlon Energy shares surged 33% to Rs 73.04 since its Q1 FY25 results on July 22, driven by a 200% YoY profit jump to Rs 302 crore. Revenue rose 50% to Rs 2,016 crore, and EBITDA increased 86% to Rs 370 crore. The stock hit a 5% upper circuit today and has reached it 7 times in 13 sessions.
Lupin shares surge 6%, hit 52-week high post robust Q1 result
Lupin Share Price: Lupin's shares jumped 6% to a 52-week high after the company announced a 77.2% increase in net profit for the June quarter of FY25. The firm's net profit was Rs 801.3 crore, and revenue rose 16.3% to Rs 5,600.3 crore. Nomura maintained a 'Buy' rating, forecasting continued growth.
Sun Pharma Q1 Results: Net profit rises 40% YoY to Rs 2,836 crore, beats estimates
Sun Pharma Q1 Results: Sun Pharma reported a 40% increase in consolidated net profit to Rs 2,836 crore, surpassing estimates of Rs 2,638 crore. Revenue rose 6% YoY to Rs 12,653 crore. EBITDA grew 8% YoY to Rs 3,608 crore with margins at 28.5%. India formulation sales reached Rs 4,144 crore, up 16%, constituting 33.1% of total sales.
Suzlon Energy Q1 Results: Cons PAT skyrockets 200% YoY to Rs 302 crore, revenue jumps 50%
Suzlon Energy Q1 Results: The renewable energy company reported a record-breaking Q1FY25, with an 86% increase in EBITDA to ₹370 crore and the highest quarterly deliveries in seven years. The strong performance was driven by a record order book of 3.8 GW, the largest in the company's 29-year history.
IRCTC, ABFRL, JSW Holdings among 453 companies declaring Q4 results on Tuesday
453 companies, including IRCTC and Aditya Birla Fashion, are set to declare Q4 results. Most companies report profits, boosting Nifty and Sensex to new highs. Market bullish ahead of Lok Sabha elections.
Q4 results today: LIC, NMDC among 236 companies to announce earnings on Monday
236 companies, including LIC and NMDC, to announce Q4 results. LIC reported a 49% rise in Q3 earnings, while NMDC saw a 62% increase in consolidated net profit.
Torrent Pharma board approves to raise Rs 5,000 crore
Torrent Pharmaceuticals, actively seeking to expand through acquisitions, has expressed interest in purchasing Mumbai-based pharmaceutical company JB Pharma, according to a report by ET on Friday.
Sun Pharma net profit jumps 34% YoY to Rs 2,654.6 crore in Q4FY24
Sun Pharma's Q4FY24 net profit rises 34% YoY to Rs 2654.6 crore, driven by increased sales of global specialty products. Interim dividend of Rs. 5 declared for FY24.
Jubilant FoodWorks Q4 Results: Profit jumps on steady demand
Jubilant FoodWorks reported a more-than-seven fold jump in quarterly profit on Wednesday as the Domino's Pizza's Indian franchisee booked an one-time gain and also benefited from steady demand.
Eris Lifesciences Q4 Results: Net profit jumps over 29% to Rs 80 crore
The Ahmedabad-based drug maker reported a net profit of Rs 61.5 crore during the corresponding quarter of the previous year. Revenue of Q4FY 24 grew by 37% YoY to Rs 551 crore. The net debt on March 31 stood at Rs 2700 crore.
Zydus Lifesciences Q4 Results: Drug makers posts threefold YoY jump in net profit to Rs 1,182 crore
Zydus Lifesciences on Friday reported Rs 1,182 crore net profit in Q4FY24, a threefold year-on-year (YoY) jump led by growth in US, India, Europe and emerging market sales.
Biocon Q4 Results: Net profit drops 57% to Rs 136 crore
Total revenue grew 1% YoY to Rs 3,966 crore. EBITDA for the quarter declined 16% YoY to Rs 964 crore, representing an EBITDA margin of 24% versus 29% in the same period last year. The gross R&D spends declined 36% YoY to Rs 228 crore in Q4FY24.
Blinkit turns adjusted EBITDA positive in March as co aggressively bets on store expansion
The company highlighted that one of the key vectors for growth for the business will come through the store expansion. In the fourth quarter, it added 75 net new stores taking the total store count to 526.
Cipla Q4 Results: Net profit jumps 79% YoY to Rs 939 crore on strong sales momentum
Cipla's North America sales, which constitute primarily US, grew 11.8% YoY to Rs 1875 crore driven by key products Lanreotide (used for treating growth hormone disorder) gaining market share to 20.8% and 12-13% Albuterol (anti-asthma inhalation) coupled with robust demand in base business.
Cipla Q4 Results: Profit soars 79% YoY to Rs 939 crore; dividend declared at Rs 13 per share
Cipla Q4 Results: Revenue from operations increased 7% year-on-year to Rs 6,163 crore in the March quarter. EBITDA for the quarter under review increased 13% year-on-year to Rs 1,316 crore as against 1166 crore in the last year period.
Dr Reddy's Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share
Dr Reddy's Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.
IDBI Bank Q4 Results: PAT soars 44% YoY to 1,628 crore; NII rises 12%
IDBI Bank's gross NPA ratio improved to 4.53% as against 6.38% YoY while net NPA ratio also improved to 0.34% vs 0.92% YoY..The lender has announced a dividend of Rs 1.50 per share which will be will be paid on approval by shareholders at the ensuing Annual General Meeting (AGM) of the bank.
V R Infraspace IPO allotment: Check status, listing date, GMP and other details
V R Infraspace IPO allotment status: V R Infraspace SME IPO allotment will be finalized today. Investors can check the status on the registrar's website. The shares are trading at a GMP of Rs 20. The IPO received 6 times subscription.
V R Infraspace IPO opens Monday. Check issue size, price band, GMP and other details
The SME IPO of V R Infraspace will open for subscription on Monday and will close on March 6. The company aims to raise Rs 20.4 crore through the IPO and list the shares on NSE SME platform. Here are 10 key things investors need to know about the public offer before subscribing to the issue.
Load More
